Straight Outta Wisconsin, LynxBio Wins EvoNexus Best Demo Vote

Via Xconomy.com


A startup team from the University of Wisconsin that moved to San Diego in January to advance their technology for optimizing treatment regimens for cancer patients won the audience vote for best pitch at the EvoNexus Spring Demo Day last week.


Lynx Biosciences founder and CEO Chorom Pak said her startup has developed microfluidic technology that uses live cancer cells to determine how multiple myeloma patients would respond to different treatment regimens. The Wednesday evening pitch event drew several hundred people to an auditorium at Qualcomm’s (NASDAQ: QCOM) corporate headquarters in San Diego.


Pak told the audience the microfluidic device can keep biopsied cancer cells alive for three days in a simulated natural environment that enables scientists to measure their behavior and response to multiple drug combinations. Pak said she has funded development of the technology through $4.3 million in non-dilutive research grants, and LynxBio is now in the process of raising $1.25 million in seed funding..


Read more »

3210 Merryfield Row

San Diego, CA 92121-1126

Stay Connected

  • White LinkedIn Icon
  • White Twitter Icon
  • Email icon-02

All content copyright © 2020 Lynx Biosciences™, Inc. All rights reserved. LynxBio   is a registered trademark of Lynx Biosciences™, Inc.

®